Biocorrx (BICX) Projected to Post Quarterly Earnings on Wednesday

Biocorrx (OTCMKTS:BICX) is anticipated to release its results before the market opens on Wednesday, February 25th. Analysts expect Biocorrx to post earnings of ($0.06) per share and revenue of $0.20 million for the quarter.

Biocorrx Stock Performance

Shares of BICX stock opened at $0.35 on Friday. The company has a market capitalization of $8.57 million, a price-to-earnings ratio of -1.09 and a beta of 0.41. Biocorrx has a 1-year low of $0.20 and a 1-year high of $0.50. The stock’s fifty day simple moving average is $0.32 and its 200-day simple moving average is $0.36.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.